ReNeuron Group’s Olav Hellebo joins Proactive to talk about their exosome technology which has shown it can deliver therapeutic proteins to a hard to access region of the human brain. Exosomes are powerful mediators that carry all the signalling and the machinery necessary to change the behaviour of a cell. As Hellobo explains, the line created by ReNeuron comes from its CTX technology and has been developed to carry the therapeutic proteins as well as delivering it to an exact destination – an area of the brain called the corpus striatum.
Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling
July 1, 2022
September 24, 2021